Guidance from the CCS COVID-19 Rapid Response Team and the CHFS
- COVID-19 and concerns regarding use of ACEi/ARB/ARNi medications for heart failure or hypertension
- Applying Ongoing Learning from the COVID-19 Pandemic Towards Optimal Cardiovascular Care in Canada
CHFS Position Statement
People with heart failure should be offered COVID-19 vaccination if they are eligible and no contraindications exist. For information about staying safe during COVID, please click here to download a patient resource developed by the Canadian Cardiovascular Society (CCS) and Heart and Stroke Foundation of Canada (HSF).
For information regarding authorized COVID-19 vaccines in Canada, please click here.